Skip to content
Global sound
AI Frontier

AI Frontier

AI drug-development push and Oracle’s $1 billion partner bet

· 2 min · Season 26 Episode 299

Show notes

Also: Ollama adds local text-to-speech for Mac AI apps

On October 23, Pathos AI said Bristol Myers Squibb and Tempus are joining it on a new AI drug-development program that starts with Alzheimer’s disease and other neurological conditions. Tempus will assemble a large de-identified patient dataset, and Pathos will use its Foundry system to test ideas about disease progression and clinical trial design at scale. Bristol Myers also led a $237 million Pathos funding round tied to the deal. The practical point is that AI is moving deeper into the expensive middle of drug development, where…

Website: spreaker.com

Live, last hour: 8,182 songs on 3,167 stations in 121 countries

Discover the world through radio

More ways to discover (7)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
House Radio IndianaContinue listening